Cambium Bio Limited (ASX:CMB)
0.3500
0.00 (0.00%)
Nov 17, 2026, 3:45 PM AEDT
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 10.3 million as of November 19, 2026. It is the 43,169th most valuable company in the world and the 1,282nd biggest in Australia. Its market cap has decreased by 11.19% in one year.
Market Cap
10.30M
Enterprise Value
9.33M
Revenue
1.23M
Global Rank
Country Rank
#1,282 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 10.30M, an increase of 29.29%. That is a compound annual growth rate of 10.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 10.30M | -4.58% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 15.55M |
| Imugene | 15.18M |
| Ceryvyn Therapeutics | 15.05M |
| EZZ Life Science Holdings | 13.65M |
| Radiopharm Theranostics | 13.01M |
| Argenica Therapeutics | 12.85M |
| Patrys | 12.81M |
| ReNerve | 12.06M |